Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Fairlie AM, Jaffee AE, Davis KC, Litt DM, Kaysen D, Norris J, Lewis MA. Establishing a new measure of alcohol-related sexual consequences and examining its association to alcohol consequences among at-risk young adults. Journal of Studies on Alcohol and Drugs 2021;82(4):593-502. [doi: 10.15288/jsad.2021.82.493] PMID: 34343081 PMCID: PMC8356789
  2. Peavy KM, Banta-Green C, Owens M. Opioids and Stimulants: What Are They and How Are People Using Them? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  3. Kingston S. WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution, September 1, 2016 – August 31, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2021
  4. Firth C, Carlini BH, Dilley J, Wakefield J, Hajat A. Moving towards equity: Neighborhood deprivation and cannabis retailers across Portland, Oregon. Cannabis 2020;3(2):157-172
  5. Yap K, Fuentes D, Moul S, Murphy C, Hartzler B, Garner B, Becker SJ. Influence of opioid treatment provider attitudes on skill and knowledge after contingency management training. [conference abstract]. Addiction Science and Clinical Practice 2020;15(suppl2):A57. [doi: 10.1186/s13722-020-00208-4]
  6. Crummy EA, Donckels EA, Baskin BM, Bentzley BS, Ferguson SM. The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse. Psychopharmacology 2020;237(1):55-68. [doi: 10.1007/s00213-019-05349-2] PMID: 31463541 PMCID: PMC7458349
  7. Banta-Green CJ, Newman A, Kingston S, Glick S, Tinsley J. Washington State Syringe Exchange Health Survey, 2019 Results. Seattle, WA: Alcohol & Drug Abuse Institute, University of Washington, 2020
  8. Hatch-Maillette MA, Donovan DM, Laschober TC. Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use. Journal of Substance Abuse Treatment 2020;116:108043. [doi: 10.1016/j.jsat.2020.108043] PMID: 32741496 PMCID: PMC7399209
  9. Vandersloot D, Stoner S, Hartzler B. Current workforce development priorities for training and technical assistance for integration of behavioral health services in medical settings. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A93. [doi: 10.1186/s13722-020-00208-4]
  10. Serafini K, Coyer C, Speights JB, Donovan DM, Guh J, Washington J, Ainsworth C. Racism as experienced by physicians of color in the health care setting. Family Medicine 2020;52(4):282-7. [doi: 10.22454/FamMed.2020.384384] PMID: 32267524
  11. Barbosa-Leiker C, Campbell ANC, Pavlicova M, Scodes J, Burlew AK, Hatch-Maillette MA, Mennenga SE, Mitchell SG, Novo P, Nunes EV, Rotrosen J, Greenfield SF. Substance use and mental health in emerging adult vs. older adult men and women with opioid use disorder. American Journal on Addictions 2020;29(6):536-542. [doi: 10.1111/ajad.13059] PMID: 32438502 PMCID: PMC7657988
  12. Stoner S, Vandersloot D, Hartzler B. Assessing perceived value of behavioral health workforce educational activities: The questions you ask matter. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A17. [doi: 10.1186/s13722-020-00208-4]
  13. Carlini BH, Harwick R, Garrett S. Anytime is the right time: A content analysis of marijuana ads in freely distributed print media in western Washington State, USA. Substance Use & Misuse 2020;55:806-817. [doi: 10.1080/10826084.2019.1703749] PMID: 31876238
  14. Schauer GL, Njai R, Grant-Lenzy AM. Modes of marijuana use – smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States. Drug and Alcohol Dependence 2020;209:107900. [doi: 10.1016/j.drugalcdep.2020.107900] PMID: 32061947
  15. Peavy KM, Darnton J, Grekin P, Russo M, Banta-Green CJ, Merrill JO, Fotinos C, Wollworth S, Soth S, Tsui JI. Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high-risk for HIV in an opioid treatment program. AIDS and Behavior 2020;24:2469-2472. [doi: 10.1007/s10461-020-02887-1] PMID: 32347404 PMCID: PMC7186943
  16. PRSC Cannabis Concentration Workgroup, Carlini B. Cannabis Concentration and Health Risks: A Report for the Washington State Prevention Research Subcommittee (PRSC). Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2020
  17. Humphreys K, Barreto N, Alessi S, Carroll K, Crits-Cristoph P, Donovan DM, Kelly J, Schottenfeld R, Timko C, Wagner T. Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials. Drug and Alcohol Dependence 2020;215;108213. [doi: 10.1016/j.drugalcdep.2020.108213] PMID: 32801112 PMCID: PMC7502458
  18. Hartzler B, Walker DD, Lyon AR, King KM, Matthews L, Ogilvie TL, Bushnell DA, Wicklander K. Applications of standardized patient methodology to enhance workshop training and assess its impact on fidelity in an implementation trial of the Teen Marijuana Check-Up. [conference abstract]. Implementation Science 2020;15(suppl2):A27
  19. Banta-Green CJ, Williams JR, Sears JM, Floyd AS, Tsui JI, Hoeft TJ. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder. Drug and Alcohol Dependence 2020;207:107799 [doi: 10.1016/J.DRUGALCDEP.2019.107799] PMID: 31865058 PMCID: PMC8085903
  20. McCarty D, Donovan DM. The National Drug Abuse Treatment Clinical Trials Network: From 2000 to 2020 and beyond [editorial]. Journal of Substance Abuse Treatment 2020;112S:1-3. [doi: 10.1016/j.jsat.2020.02.010]